|
 |
||
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 Project Summary  Ann Olincy, M.D. (Young Investigator 2002) of University of Colorado, Denver, will examine if the decrease in lung disease, as indicated by bombesin-like peptide (lung cells produce these in response to nicotine stimulation; they have been found to be reduced in patients with schizophrenia) levels, in patients taking clozapine, is related to protective effects of this medication or to decreased nicotine exposure. It is believed that smoking is a form of self-treatment for people with schizophrenia, based on the hypothesis that nicotine corrects neuronal defects involved in the pathophysiology of schizophrenia. Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia\Nicotine |
Announcements
NARSAD Award Winners
 Colleen Ann McClung, Ph.D., UT Southwestern Medical Center at Dallas, 2005 & 2007 Young Investigator Latest News from NARSAD
|
